Season 7 | Episode 9
Dr. Vaishnavi Kundel, Rammi n. Khayat, MD, Dr. Aneesa Das | Company
On this episode, Dr. Seema Khosla examines the complexities of central sleep apnea (CSA) with sleep medication specialists Dr. Vaishnavi Kundel, Dr. Rami N. Khayat, and Dr. Aneesa Das. The dialogue strikes past primary definitions to discover the crucial limitations of house sleep apnea testing in precisely detecting CSA and when in-lab polysomnography turns into important.
The dialog addresses necessary scientific distinctions between post-arousal, transitional, and combined apneas, difficult frequent assumptions about their significance and therapy approaches. The panel supplies readability on numerous CSA etiologies, together with coronary heart failure-related periodic respiration, medication-induced central apneas, treatment-emergent CSA, and neurological problems.
Uncover evidence-based views on therapy methods, together with up to date views on adaptive servo-ventilation because the SERVE-HF trial, indications for phrenic nerve stimulation, and the potential of mixture therapies. Be taught when to think about various approaches like dead-space air flow, supplemental oxygen, and acetazolamide, both alone or as a part of hybrid therapy plans.
The dialogue additionally examines sensible scientific questions: Does distinguishing between obstructive and central apnea matter if therapy approaches overlap? When ought to sufferers with suspected CSA bear in-lab research versus house testing? What steerage ought to clinicians comply with for sufferers with ejection fractions under 45%? Whether or not you’re managing advanced sleep problems or encountering CSA in major care, this episode supplies important insights for optimizing affected person outcomes by means of correct prognosis and acceptable therapy choice.